Digoxin injection contains propylene glycol as an excipient. This ingredient is used to help dissolve the active drug, digoxin, in the injectable solution. Propylene glycol is a common solvent and humectant in pharmaceutical formulations.
Why is Propylene Glycol Used in Digoxin Injection?
Propylene glycol serves as a solvent to ensure that digoxin, which has limited solubility in water, can be effectively dissolved for parenteral administration. Its presence facilitates the creation of a stable and deliverable liquid formulation [1].
Are There Alternatives to Propylene Glycol in Digoxin Formulations?
While propylene glycol is a common excipient, pharmaceutical formulations can vary. Alternative solvents or co-solvents might be employed in different digoxin formulations, though specific details depend on the manufacturer and the exact product. Information on alternative excipients for digoxin injections can often be found in product inserts or regulatory filings [1].
What are the Potential Concerns with Propylene Glycol?
Propylene glycol can cause adverse effects in some individuals, particularly with prolonged exposure or high doses. These can include central nervous system depression, hyperosmolality, and lactic acidosis, especially in patients with renal impairment. Neonates and critically ill patients may be more susceptible to these risks [2]. The concentration and route of administration are key factors in determining the potential for adverse events.
How is Digoxin Injection Administered?
Digoxin injection is administered intravenously or intramuscularly by a healthcare professional. It is typically used when oral administration is not feasible or when a rapid onset of action is required.
Who Manufactures Digoxin Injection?
Various pharmaceutical companies manufacture digoxin injection. Specific brand names and manufacturers can be identified through drug databases or by consulting a healthcare provider. For instance, companies like Amneca Pharmaceuticals LLC have marketed digoxin injection [3].
When Does the Patent for Digoxin Injection Expire?
Digoxin is a well-established drug, and its original patents have long expired. This means that generic versions of digoxin injection have been available for many years. Patent information for specific formulations or manufacturing processes would be detailed and may differ, but the core patent protection for digoxin itself is no longer in effect [4]. DrugPatentWatch.com provides resources for tracking patent expirations for various drugs.
Can Biosimilars Be Developed for Digoxin Injection?
As digoxin is a small molecule drug, the concept of biosimilars, which applies to large molecule biologics, is not directly applicable. However, generic versions of digoxin injection are widely available due to the expiration of its original patents.
What is the Dosage and Pricing of Digoxin Injection?
Dosage for digoxin injection is determined by a healthcare provider based on the patient's condition, age, and renal function. Pricing can vary significantly depending on the manufacturer, dosage strength, quantity, and insurance coverage. Generic formulations are generally more cost-effective.
What Clinical Data Supports the Use of Digoxin Injection?
Clinical data supporting the use of digoxin injection dates back many decades, establishing its efficacy in treating heart failure and certain arrhythmias, such as atrial fibrillation. Studies have demonstrated its ability to improve symptoms of heart failure and control heart rate in atrial fibrillation [5].
Patient Concerns Regarding Digoxin Injection
Patients may have concerns about potential side effects of digoxin, including nausea, vomiting, vision changes (like blurred vision or yellow/green halos), and irregular heart rhythms. The presence of excipients like propylene glycol can also be a point of inquiry, particularly for patients with known sensitivities or underlying health conditions.
Sources:
[1] https://www.accessdata.fda.gov/drugsatfdadocs/label/2004/050722s020lbl.pdf
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810764/
[3] https://www.accessdata.fda.gov/scripts/drugshortages/dspActiveIngredientDetails.cfm?IngredientName=DIGOXIN
[4] https://www.drugpatentwatch.com/
[5] https://www.ahajournals.org/doi/10.1161/01.cir.90.4.1897